Understanding why people are hesitant to get vaccinated against COVID-19
Vaccine Hesitancy: Exploring the Role of Temporal and Cross-country Variation in COVID Rules, Vaccine Media Coverage, and Public Health Policy Consistency
This study looks at why some people in sixteen different countries are hesitant to get the COVID-19 vaccine by examining things like vaccination rules, news coverage, and health advice, so we can better understand and help those who are unsure about getting vaccinated.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10792031 on NIH RePORTER |
What this research studies
This research investigates the factors influencing vaccine hesitancy regarding COVID-19 vaccinations across sixteen countries. By analyzing variations in vaccination policies, media coverage, and public health guidelines over time, the study aims to understand how these elements affect individuals' willingness to get vaccinated. The research will utilize both national and sub-national data to explore demographic characteristics and their relationship with vaccination rates. This comprehensive approach seeks to identify the reasons behind vaccine hesitancy and inform future public health strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from diverse demographic backgrounds who have shown hesitancy or reluctance to receive the COVID-19 vaccine.
Not a fit: Patients who are already vaccinated or have no concerns about vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved public health policies that encourage higher vaccination rates and better health outcomes.
How similar studies have performed: Previous research has shown that understanding public attitudes and behaviors towards vaccination can significantly improve vaccination uptake, indicating that this approach has potential for success.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Lillard, Dean R — Ohio State University
- Study coordinator: Lillard, Dean R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.